Le, X., Cornelissen, R., Garassino, M., Clarke, J. M., Tchekmedyian, N., Goldman, J. W., . . . Socinski, M. A. (2021). Poziotinib in Non–Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial. Journal of clinical oncology, 40(7), 710-718.
Chicago Style (17th ed.) CitationLe, Xiuning, et al. "Poziotinib in Non–Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial." Journal of Clinical Oncology 40, no. 7 (2021): 710-718.
MLA (8th ed.) CitationLe, Xiuning, et al. "Poziotinib in Non–Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial." Journal of Clinical Oncology, vol. 40, no. 7, 2021, pp. 710-718.
Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.
Visit our Citation Styles guide for help on properly citing sources.